Tenax Therapeutics Inc has a consensus price target of $30 based on the ratings of 1 analysts. The high is $30 issued by Roth MKM on February 20, 2024. The low is $30 issued by Roth MKM on February 20, 2024. The 3 most-recent analyst ratings were released by Roth MKM on February 20, 2024, November 13, 2023, and March 7, 2023, respectively. With an average price target of $14 between Roth MKM, there's an implied 292.16% upside for Tenax Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Tenax Therapeutics (NASDAQ:TENX) was reported by Roth MKM on February 20, 2024. The analyst firm set a price target for $30.00 expecting TENX to rise to within 12 months (a possible 740.34% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Tenax Therapeutics (NASDAQ:TENX) was provided by Roth MKM, and Tenax Therapeutics reiterated their buy rating.
There is no last upgrade for Tenax Therapeutics
There is no last downgrade for Tenax Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenax Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenax Therapeutics was filed on February 20, 2024 so you should expect the next rating to be made available sometime around February 20, 2025.
While ratings are subjective and will change, the latest Tenax Therapeutics (TENX) rating was a reiterated with a price target of $0.00 to $30.00. The current price Tenax Therapeutics (TENX) is trading at is $3.57, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.